Comparison and imputation-aided integration of five commercial platforms for targeted DNA methylome analysis. (2022)
Attributed to:
Development of the UroMark assay. A non-invasive test for the detection of bladder cancer in urinary sediment cells
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41587-022-01336-9
PubMed Identifier: 35654977
Publication URI: http://europepmc.org/abstract/MED/35654977
Type: Journal Article/Review
Volume: 40
Parent Publication: Nature biotechnology
Issue: 10
ISSN: 1087-0156